This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
TSN Q2 Earnings Top Estimates, Sales Flat Amid Volume Pressure
by Zacks Equity Research
Tyson Foods' Q2 results reflect the higher earnings. However, revenues remain flat as strong pricing mitigates the volume slump.
Hershey Q1 Earnings Top Estimates, Sales Down Amid Volume Pressure
by Zacks Equity Research
HSY's first-quarter results reflect lower year-over-year earnings and sales amid economic uncertainty and heightened cost pressure.
Church & Dwight Q1 Earnings Beat Estimates, Lower Organic Sales Hurt
by Zacks Equity Research
CHD posts earnings beat in first-quarter 2025. Net sales dip 2.4% year over year on lower organic sales.
Service Corp Q1 Earnings Beat Estimates, Funeral Revenues Rise
by Zacks Equity Research
SCI's first-quarter results reflect higher year-over-year revenues and earnings. Also, the gross margin expanded 90 basis points year over year to 27.1%.
PPC Q1 Earnings Beat Estimates, U.S. Operations Drive Sales Growth
by Zacks Equity Research
Pilgrim's Pride's first-quarter results show 2.3% year-over-year revenue growth, supported by gains in U.S. operations.
Should Value Investors Buy Associated British Foods (ASBFY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sprouts Farmers Q1 Earnings Surpass Estimates, Comp Sales Up 11.7%
by Zacks Equity Research
Sprouts Farmers registers strong comparable sales growth, positive traffic trends and robust e-commerce performance in Q1.
Mondelez Q1 Earnings Beat Estimates, Net Revenues Rise 0.2% Y/Y
by Zacks Equity Research
MDLZ's first-quarter results reflect strong organic growth, resilient pricing and gains from the Evirth acquisition.
Newell's Q1 Loss Narrower Than Expected, Core Sales Down 2.1%
by Zacks Equity Research
NWL reports a sales decline in first-quarter 2025, owing to a core sales drop of 2.1% year over year.
Here's How Colgate is Poised Post Q1 Earnings: Buy or Hold the Stock?
by Zacks Equity Research
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
MO Q1 Earnings Beat Estimates, Sales Decline on Low Cigarette Volumes
by Zacks Equity Research
Altria's Q1 results reflect increased earnings on higher operating income. Management expects earnings growth in 2025.
Kraft Heinz's Q1 Earnings Beat Estimates, 2025 View Lowered
by Zacks Equity Research
KHC's first-quarter sales meet the Zacks Consensus Estimate, while organic net sales decline 4.7% amid volume/mix pressures.
TAP's Innovations on Track: Topo Chico Hard Debuts Margarita Beverages
by Zacks Equity Research
Molson Coors is focused on portfolio premiumization and innovations. Topo Chico Hard Seltzer is extending its portfolio into flavored alcoholic beverages.
SYY Q3 Earnings Miss on External Pressures, Weak Consumer Confidence
by Zacks Equity Research
Sysco's fiscal third-quarter results show y/y sales growth. However, the company focuses on growth and plans significant shareholder returns.
Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y
by Zacks Equity Research
MED's first-quarter results show challenges from fewer active OPTAVIA Coaches. Nonetheless, the company is focusing on revitalizing its coach base for growth.
Colgate Q1 Earnings & Sales Beat Estimates, Organic Sales Rise 1.4%
by Zacks Equity Research
CL posts better-than-expected first-quarter 2025 results. Results benefited from organic sales growth, robust volume and pricing performance.
Helen of Troy Shares Down on Q4 Earnings Miss, Sales Decline Y/Y
by Zacks Equity Research
HELE's fiscal fourth-quarter results reflect a 0.7% sales dip, due to a 4.9% decline in organic business sales.
Procter & Gamble Meet Earnings Estimates in Q3, Organic Sales Up 1% Y/Y
by Zacks Equity Research
PG matches earnings estimates in third-quarter fiscal 2025, while sales remain soft. Organic sales grew year over year, driven by the rise in pricing.
Philip Morris Q1 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
PM's first-quarter 2025 results reflect increased earnings and sales on robust momentum across all regions.
Kimberly-Clark's Q1 Earnings Top Estimates, Organic Sales Down 1.6%
by Zacks Equity Research
KMB's first quarter sales dip 6%, with organic sales declining 1.6%. Management updates 2025 outlook amid cost pressures and global headwinds.
3 Miscellaneous Food Stocks to Buy Despite Prevailing Industry Setbacks
by Nalak Das
Three miscellaneous food stocks have strong short-term price upside potentials. These are: CELH, UNFI, UTZ.
Should You Buy Dollar General Stock at Its Current Valuation?
by Zacks Equity Research
Dollar General is trading well below its industry peers, but is this a golden buying opportunity? Here's what investors need to know before jumping in.
POST Stock Trades Above 50 & 200-Day SMA: What Should Investors Do?
by Zacks Equity Research
Post Holdings drives growth through acquisitions and pricing strength, while tackling cost pressures and soft volumes in key segments.
Should You Buy Central Garden and Pet Stock at its Current Valuation?
by Zacks Equity Research
CENT is driving growth through innovation, operational efficiency and strong earnings momentum, positioning itself for continued success.
Albertsons' Q4 Earnings Beat Estimates, Pharmacy Sales Rise 18% Y/Y
by Zacks Equity Research
ACI's fourth-quarter fiscal 2024 results showcase strong year-over-year growth in digital sales, pharmacy operations and membership in its loyalty program.